集体跳水！明天关注一件大事

Market Overview - A-shares experienced narrow consolidation today with total trading volume at 1.24 trillion, unchanged from yesterday [1] - The brain-computer interface sector saw a surge with stocks like Aipeng Medical, Innovation Medical, and Nanjing Panda hitting the daily limit [1] Brain-Computer Interface Developments - The brain-computer interface field has made significant progress this year, highlighted by Brain Regeneration Technology's announcement of its new neural modulation chip receiving FDA clinical trial approval [1] - The company plans to collaborate with the Mayo Clinic for Parkinson's disease treatment research, marking a frontier in brain-computer interface technology [1] Stock Performance and Market Sentiment - There was a noticeable divergence in popular stocks today, with previously high-performing stocks experiencing significant declines [1] - The A+H shares in new consumption, pharmaceuticals, and IP economy sectors saw substantial pullbacks, raising questions about whether the recent rally has peaked [1][3] Sector Analysis - The trading congestion in the innovative drug and new consumption sectors has reached high levels, indicating potential short-term overheating in market sentiment [3] - Analysts suggest that the recent rally in these sectors may have reached a temporary peak, with some funds looking to shift strategies [3][4] Future Market Outlook - Despite the current adjustments, it may be premature to conclude that the new consumption and innovative drug sectors have ended their upward trends [4] - Analysts from Huatai Securities indicate that after a period of adjustment, there could be better entry opportunities in these sectors [4] Upcoming Financial Events - The 2025 Lujiazui Forum will be held from June 18 to 19 in Shanghai, focusing on financial openness and high-quality development [6] - Major financial policies are expected to be announced during the forum, which could provide support for bank stock valuations [6]